BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16056188)

  • 1. The diagnostic possibilities of positron emission tomography (PET): applications in oral and maxillofacial buccal oncology.
    Carranza-Pelegrina D; Lomeña-Caballero F; Soler-Peter M; Berini-Aytés L; Gay-Escoda C
    Med Oral Patol Oral Cir Bucal; 2005; 10(4):331-42. PubMed ID: 16056188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
    Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
    Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in cancer of the head and neck.
    Hain SF
    Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer.
    McCollum AD; Burrell SC; Haddad RI; Norris CM; Tishler RB; Case MA; Posner MR; Van den Abbeele AD
    Head Neck; 2004 Oct; 26(10):890-6. PubMed ID: 15390197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron-emission tomography for surveillance of head and neck cancer.
    Ryan WR; Fee WE; Le QT; Pinto HA
    Laryngoscope; 2005 Apr; 115(4):645-50. PubMed ID: 15805874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
    Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
    Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
    J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PET/CT in maxillo-facial surgery.
    Wong WL; Batty V
    Br J Oral Maxillofac Surg; 2009 Jun; 47(4):259-67. PubMed ID: 19200626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
    Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
    Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
    Jones J; Farag I; Hain SF; McGurk M
    Eur J Surg Oncol; 2005 Mar; 31(2):170-6. PubMed ID: 15698734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
    Kutler DI; Wong RJ; Schoder H; Kraus DH
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma.
    Lee JC; Kim JS; Lee JH; Nam SY; Choi SH; Lee SW; Kim SB; Kim SY
    Oral Oncol; 2007 Aug; 43(7):686-92. PubMed ID: 17112775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.